 What is the central question of this study? Disrupting circadian rhythms in rodents 1 perturbs glucose metabolism and increases adiposity. In this study we asked whether 2 circadian rhythm disruption, induced by exposure of sheep to rapidly alternating 3 photoperiods (RAP), also disrupts metabolic homeostasis in a large diurnal animal 4 model. 5
 What is the main finding and its importance? RAP exposure disrupted central 6 (melatonin and core body temperature) and peripheral (skeletal muscle clock gene 7 expression) rhythmicity. This led to reduced nocturnal plasma glucose concentrations, 8 but did not affect glucose tolerance and glucose stimulated insulin secretion. These 9 results suggest that RAP-induced circadian rhythm disruption has minimal effect on 10 glucose homeostasis in the sheep. 11 12 colourimetrically on a Hitachi 912 Automatic Analyzer using kits obtained from Roche 1
Diagnostics (Mannheim, Germany). 2 3

Gene expression analyses 4
Gene expression in muscle biopsies was measured by Real Time RT-PCR using primers 5 specific for the clock genes Bmal1, Clock, Per1, Per2, Per3, Cry1, Cry2, Dec1, Nr1d1 (Rev-6 erbα), Nr1d2 (Rev-erbβ), Nr1f1 (RORα) and Nr1f3 (RORγ) , and the metabolic genes 7 peroxisome proliferator-activated receptor alpha (Pparα), peroxisome proliferator-activated 8 gamma co-activator 1 alpha (Pgc1α) and nicotinamide phosphoribosyltransferase (Nampt). 9
Sheep mRNA primers were designed for each gene of interest within NCBI nucleotide (Table  10 1). In brief, muscle biopsies (50-100 mg) were homogenised in 1 ml of TriReagent (Sigma 11 Aldrich, St. Louis, MO) using a PowerLyzer 24 (Mo Bio Laboratories, Carlsbad, CA), and 12 RNA extracted according to the manufacturer's protocol. Residual contaminating DNA from 13 all samples was removed using Ambion DNAfree™ kits (Life Technologies, Carlsbad, CA). 14 RNA was reverse transcribed using a Superscipt III reverse transcription kit (Life 15 Technologies) and random hexamer primers (Geneworks, Adelaide, Australia). Amplification 16 of cDNA was performed on a GeneAmp 7500 Sequence Detection System (Life 17 to a calibrator using the ∆∆Ct method. For each gene, the calibrator was designated as the 20 time point of maximal expression under control conditions and was set as 1 (Varcoe & 21 Kennaway, 2008) . 22 
23
Data analysis
Statistical analyses were conducted using SPSS v.20. Circulating melatonin, glucose and 1 insulin concentrations, and gene expression data were analysed using two-factor repeated 2 measures ANOVA with post-hoc Bonferroni tests to compare conditions (control cf. RAP) at 3 individual time points, during the 24-hour collection periods in both groups, i.e. comparisons 4 between 24-hour measures made during control conditions and at 48-72 hours following the 5 last phase shift during RAP. Data within each condition, including longer sampling periods 6 where appropriate, was also analysed for effects of time using one-way repeated measures 7 ANOVA with post-hoc Bonferroni tests. Additionally, Circwave analyses (developed by R.A 8 Hut, http://hutlab.nl, (Oster et al., 2006) were performed for gene expression measures during 9 control and RAP conditions to determine whether gene expression data fit to a sine curve 10 with a 24 hour period, and the times of peak and trough gene expression for each 11 experimental condition. Data are presented as mean ± SEM unless otherwise stated. P < 0.05 12 was accepted as significant. 13
14
RESULTS 1
Body weight and food consumption 2 Sheep gained 9.7 ± 1.5 kg from the time of arrival in the facility to completion of the 3 experiment and were 6.8 ± 0.8 kg heavier at the time of data collection following RAP 4 exposure (week 8) than during control data collection (week 3, P < 0.001, Table 2 ). However, 5 the rate of weight gain did not differ between control and RAP conditions (P > 0.05). Chaff 6 consumption was not different between conditions (P > 0.05, Table 2 ). Absolute daily sheep 7 pellet consumption was higher when the ewes were exposed to RAP than control (P < 0.05, 8 Table 2 ), but did not differ between conditions when expressed relative to body weight (P > 9 0.05). 10
11
Circulating melatonin, glucose and insulin 12
Plasma melatonin concentrations (Figure 2A ) of sheep maintained on a control photoperiod 13 changed with time (P < 0.001), with high nocturnal concentrations evident at ZT16 (120 ± 36 14 pg/ml) and ZT20 (117 ± 25 pg/ml), which declined to 24 ± 4 pg/ml at the time of lights on 15 (ZT0). Following exposure to 4 weeks of RAP, plasma melatonin concentration also changed 16 with time (P < 0.001) with peak secretion still occuring during the dark phase at ZT16-20. 17
During the first night of collections (12-24 hours after the last shift), however, melatonin 18 secretion following RAP was reduced by ~40% compared to secretion at the same zeitgeber 19 time on the last night of collections, 60-72 hours after the last shift. Plasma melatonin in the 20 first 24 h after the final phase shift peaked briefly at 70 ± 26 pg/ml at ZT16 (P > 0.05 21 compared to the final night of collections), then decreasing to 19 ± 7 pg/ml at ZT20 (P < 22 0.01) and 7.5 ± 0.6 pg/ml at ZT0 (P<0.05). The following night, 36-48 hours after the last 23 shift, the pattern of secretion had returned to that observed under control conditions, withhigh levels at night and low levels during the day (P > 0.05 compared to final night of 1 collections). 2 3 Plasma glucose concentrations ( Figure 2B ) of sheep maintained on the control photoperiod 4 changed with time (P < 0.05), with peak concentrations of 4.0 ± 0.03 mM occuring at ZT16 5 and a nadir of 3.6 ± 0.1 mM at ZT4. Plasma glucose following RAP exposure also changed 6 with time (P < 0.05) with peak levels occurring during the day rather than at night as seen 7 during control conditions. Effects of condition varied with sample time (condition X time 8 interaction, P < 0.05), such that plasma glucose was lower under RAP than control conditions 9 at 48 h (ZT0), 60 h (ZT12) and 64 h (ZT16) after the final phase shift (each P < 0.05). 10
Condition did not alter plasma insulin (P > 0.05, Figure 2C ), which did not change with time 11 under the control conditions (P > 0.05). Under RAP conditions, plasma insulin changed with 12 time during the 72 h after the final phase change (P < 0.05), such that plasma insulin 13 concentrations were highest during the day, and lowest at the time of lights on. Effects of condition varied with sample time (condition X time interaction) for the expression 5 of Bmal1 (P < 0.05) and Nr1d1 mRNA (P < 0.05), with RAP exposure phase advancing the 6 peak expression of these genes by 2.5 and 2 hours respectively. Condition also altered Per1 7 (P < 0.05) and Nr1d2 mRNA (P < 0.05) expression such that RAP decreased Per1 mRNA 8 expression at ZT0 and ZT6, and of Nr1d2 mRNA at ZT12 compared to control conditions. 9
Expression of Clock, Per2, Dec1, Cry1, Cry2, Nr1f1 and Nr1f3 mRNA was similar under 10 control conditions and after RAP (each P > 0.05). The main purpose of this study was to evaluate the impact of rapidly alternating photoperiods 2 on central and peripheral rhythmicity, and to determine how this impacts upon a range of 3 metabolic outcomes. We found that under a control 12L:12D photoperiod, adult ewes express 4 stable central and peripheral rhythms including the nocturnal secretion of melatonin, regular 5 changes in core body temperature and, for the first time, also rhythmic clock gene expression 6 in skeletal muscle. These variables were each affected by RAP exposure, indicative of an 7 attempt by the ewes to adjust to the changing photoperiod. While there were some metabolic 8 changes observed following RAP exposure, in particular lower plasma glucose levels at 9 night, there was no effect of treatment upon food consumption, glucose tolerance, glucose 10 stimulated insulin secretion, or metabolic gene expression in skeletal muscle. 11
12
In the current study, RAP exposure affected the normal pattern of melatonin secretion, such 13 that circulating concentrations during the first night after resumption of the normal 14 photoperiod were lower than that under control conditions. This response has been observed 15 melatonin rhythms to adjust to a change in phase of the photoperiod. When rats were exposed 23 to a phase delay of the photoperiod through extension of the dark period by 12 hours, it took 24 up to a week for melatonin secretion to completely entrain (Liu & Borjigin, 2005) . However,further analysis of the data reveals that in fact the onset of melatonin secretion immediately 1 phase locked with the new photoperiod, whereas the timing of melatonin offset gradually 2 realigned over subsequent days. In our previous studies we also found that following 3 exposure of pregnant rats to a similar protocol of rapidly alternating photoperiods, melatonin 4 secretion on the night following return to the original photoperiod was very similar to that of 5 control rats maintained on an unchanging photoperiod, with high secretion at night (Varcoe et 6 al., 2013) . The two protocols did however differ slightly, such that the last photoperiod 7 reversal occurred through an extension to the dark phase in the rat model, whereas here in 8 sheep the light phase was extended. Given that we did not assess melatonin secretion during 9 the time of photoperiod reversal, we cannot determine the degree of adjustment required to 10 re-align to the original photoperiod. Nevertheless, together the previous studies in rats and 11 our work here in sheep demonstrate that melatonin secretion adjusts relatively quickly to 12 large phase shifts of the photoperiod. 13
14
In contrast to the centrally-regulated rhythms of melatonin and core body temperature, 15 muscle cellular rhythmicity in these sheep had not adjusted to the current photoperiod 2 days 16 after the last photoperiod shift. At this time the rhythm of expression of Bmal1, Clock, Nr1d1 17 and Cry2 mRNA in skeletal muscle was phase advanced by 2 -3.5 hours following RAP 18 exposure compared to the control photoperiod. Together these results suggest that in sheep, 19 central rhythmicity adjusts to a phase shift of the photoperiod faster than peripheral rhythms, 20 consistent with previous reports in rats (Yamazaki et al., 2000) . (Polidarova et al., 2013) . Interestingly, the phase of expression 4 of the clock genes in humans is in antiphase to that observed in nocturnal species. In 5 particular, highest expression of Bmal1 mRNA occurs at dusk, whereas the Period and 6
Cryptochrome genes peak around dawn in human adipose tissue (Otway et al., 2011) . The 7 similar profiles of rhythmic clock gene expression we observed here in sheep skeletal muscle 8
suggests that other diurnal species may share similar profiles, and further suggest that the 9 sheep will be a useful animal model for interrogating the effects of circadian rhythms and 10 their disruption in human physiology. that regulate the expression of these genes within muscle, may differ between species. 10 Nevertheless, the lack of rhythmic metabolic gene expression in sheep skeletal muscle 11 observed here suggests that the relationship between cellular clocks and metabolic function 12 may vary between species, and further work is needed to assess this. Furthermore, this effect was maintained for 4 days, with decreased fasting glucose after RAP 24 still evident prior to the IVGTT, 4 days after the final phase-shift. A possible explanation forreduced plasma glucose concentrations after RAP exposure could be altered timing of food 1 consumption. Exposure of pregnant rat dams to a similar RAP protocol led to intermittent 2 grazing rather than consolidated bouts of feeding during the dark period . 3
While we know that the ewes in the current study did not alter their total food consumption 4 relative to body weight in response to RAP, we do not know at what time of day the food was 5 consumed. Changes to food consumption may also underlie the changing insulin profile 6 observed following RAP. Under control conditions, insulin levels were constant across 24 7 hours, whereas following RAP, insulin concentrations are elevated during the light period. It 8 would be interesting to continue the RAP exposure for longer to determine if these changes in 9 plasma glucose and insulin profiles were maintained and if they led to an altered metabolic 10 
